サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血漿療法の世界市場（2022年～2028年）
市場調査レポート
商品コード
1078013

血漿療法の世界市場（2022年～2028年）

Global Plasma Therapy Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血漿療法の世界市場（2022年～2028年）
出版日: 2022年04月13日
発行: Orion Market Research
ページ情報: 英文 110 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿療法の市場規模は、予測期間中にCAGRで13.1%の成長が予測されています。技術の進歩と、生命に関わる数々の症状における血漿療法の利用が、市場を促進すると予想されます。

当レポートでは、世界の血漿療法市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。

目次

第1章 レポートサマリー

第2章 市場概要と考察

  • 調査範囲
  • アナリストの考察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の発展
  • 主要戦略分析
  • 主要企業に対するCOVID-19の影響

第4章 市場セグメンテーション

  • 世界の血漿療法市場：タイプ別
    • 多白血球フィブリン
    • ピュア多血小板フィブリン
    • 多白血球PRP
    • ピュアPRP
  • 世界の血漿療法市場：用途別
    • 整形外科
    • 皮膚科
    • 歯科
    • その他（神経損傷）
  • 世界の血漿療法市場：エンドユーザー別
    • 病院・診療所
    • 研究機関

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • その他の地域

第6章 企業プロファイル

  • Baxter International
  • Biolife Plasma Services
  • Biotest
  • Bio Product Laboratory Ltd. (BPL)
  • CSL LTD.
  • China Biologic Products, Inc.
  • Grifols International S.A.
  • Johnson and Johnson, Inc.
  • Kedrion S.P.A.
  • LFB SA
  • Octapharma Plasma
  • Ge Healthcare
  • Arthrex Inc
  • Regen Lab
  • Tri-Star Technologies
図表

LIST OF TABLES

  • 1. GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBALLEUKOCYTE-RICH FIBRINPLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL PURE PLATELET-RICH FIBRINPLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL LEUKOCYTE-RICH PRPPLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL PURE PRPPLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 7. GLOBAL PLASMA THERAPY IN ORTHOPAEDICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL PLASMA THERAPY IN DERMATOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL PLASMA THERAPY IN DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL PLASMA THERAPY IN OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL BOTTLED PLASMA THERAPY IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL PLASMA THERAPY IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BYAPPLICATION, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BYAPPLICATION, 2021-2028 ($ MILLION)
  • 21. EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 22. ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 23. ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BYEND-USER, 2021-2028 ($ MILLION)
  • 26. REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 27. REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL PLASMA THERAPY MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL PLASMA THERAPY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL PLASMA THERAPY MARKET, 2022-2028 (%)
  • 4. GLOBAL PLASMA THERAPY MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBALLEUKOCYTE-RICH FIBRIN PLASMA THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL PURE PLATELET-RICH FIBRIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL LEUKOCYTE-RICH PRP MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBALPURE PRP PLASMA THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL PLASMA THERAPY MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 10. GLOBAL PLASMA THERAPY FOR ORTHOPAEDICSMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL PLASMA THERAPY FOR DERMATOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL PLASMA THERAPY FOR DENTAL MARKET SHARE BYGEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBALPLASMA THERAPY FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL PLASMA THERAPY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 15. GLOBAL PLASMA THERAPY IN HOSPITALS AND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL PLASMA THERAPY IN RESEARCH INSTITUTE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. US PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CANADA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. UK PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. FRANCE PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. GERMANY PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. ITALY PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. SPAIN PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. REST OF EUROPE PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. INDIA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. CHINA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. JAPAN PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. SOUTH KOREA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: PH-1311

Global Plasma Therapy Market Size, Share & Trends Analysis Report by Type (Leukocyte-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (PRF), Leucocyte-Rich PRP, and Pure PRP), by Application (Orthopedics, Dermatology, Dental, and Others), and by End-User (Hospitals & Clinics and Research Institutions) Forecast Period (2022-2028)

The global plasma therapy market is anticipated to grow at a significant CAGR of 13.1% during the forecast period. Red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma make up blood. Plasma makes up 55% of the entire volume of blood. Plasma transports hormones, proteins, and nutrients to many regions of the body in addition to RBCs, WBCs, and platelets. Plasma therapy allows a healthy recovered person's immunity to be transferred to a patient since plasma has a high concentration of antibodies. Plasma therapy has been used in dentistry, orthopedics, and dermatology for a long time. Plasma therapy is commonly used to treat wounds, face restoration, and androgenetic alopecia. Technological advances and the use of plasma therapy in numerous life-threatening conditions are expected to propel the global plasma therapy market forward.

The global plasma therapy market is segmented based on type, application, and end-user. Based on type, the plasma therapy market is segmented into leukocyte-rich fibrin (L-PRF), pure platelet-rich fibrin (PRF), leucocyte-rich PRP, and pure PRP. The pure PRP segment is estimated to account for the largest share of the global market during the forecast period. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, the lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market. Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. Based on end-user, the market is classified into hospitals & clinics, and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market during the forecast period.

The global plasma therapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American region is anticipated to be the fastest-growing region in the plasma therapy market owing to the growing number of hospitals and clinics which is increasing the demand for plasma therapy. The key driving forces expected to boost the market of plasma therapy in North America are rising awareness levels among blood donors, the presence of advanced protein fractioning procedures, and higher per capita income in developed countries.

The major companies serving the global plasma therapy market include Arthrex Inc., China Biologic Products Inc., and Johnson and Johnson. The companies are focusing on product innovations, expansions, mergers & acquisitions, and finding a new market or innovation in their core competency to expand individual market share. For instance, Grifols SA struck an agreement with GC Pharma Group in July 2020 to acquire its Montreal-based plasma fractionation facility and two purification facilities, as well as 11 plasma collection centers in the US.

Research Methodology

The market study of the globalplasma therapymarket is incorporated by extensive primary and secondary research conducted by the research team at OMR.Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Plasma Therapy Market Research and Analysis by Production.

2. Global Plasma Therapy Market Research and Analysis byCategory.

3. Global Plasma Therapy Market Research and Analysis by Packaging.

The Report Covers

  • Comprehensive research methodology of the global plasma therapymarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global plasma therapy market.
  • Insights about market determinants that are stimulating the global plasma therapymarket.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

Category- Pharmaceuticals

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Plasma Therapy Market
  • Recovery Scenario of Global Plasma Therapy Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

  • 4.1. Global Plasma Therapy Market by Type
    • 4.1.1. Leukocyte-Rich Fibrin
    • 4.1.2. Pure Platelet-Rich Fibrin
    • 4.1.3. Leukocyte-Rich PRP
    • 4.1.4. Pure PRP
  • 4.2. Global Plasma Therapy Market by Application
    • 4.2.1. Orthopedics
      • 4.2.1.1. Arthritis
      • 4.2.1.2. Chronic Tendinitis
      • 4.2.1.3. Bone Repair & Regeneration
    • 4.2.2. Dermatology
      • 4.2.2.1. Androgenic Alopecia
      • 4.2.2.2. Plastic Surgery
    • 4.2.3. Dental
    • 4.2.4. Others (Nerve Injury)
  • 4.3. Global Plasma Therapy Market by End-User
    • 4.3.1. Hospitals and Clinics
    • 4.3.2. Research Institute

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Baxter International
  • 6.2. Biolife Plasma Services
  • 6.3. Biotest
  • 6.4. Bio Product Laboratory Ltd. (BPL)
  • 6.5. CSL LTD.
  • 6.6. China Biologic Products, Inc.
  • 6.7. Grifols International S.A.
  • 6.8. Johnson and Johnson, Inc.
  • 6.9. Kedrion S.P.A.
  • 6.10. LFB SA
  • 6.11. Octapharma Plasma
  • 6.12. Ge Healthcare
  • 6.13. Arthrex Inc
  • 6.14. Regen Lab
  • 6.15. Tri-Star Technologies